# Protalix BioTherapeutics, Inc.: Form 8-K, filed Aug 8, 2019

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2019-08-08
- Accepted by EDGAR: Aug 8, 2019, 06:19 ET
- Period: 2019-08-08
- Accession: 0001144204-19-038367
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420419038367/tv527041_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420419038367/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420419038367/tv527041_8k.htm

Filed Aug 8, 2019.
Source: SEC EDGAR, the filing index for accession 0001144204-19-038367. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
